Soejima T, Hirota S, Hishikawa Y, Hamanaka A, Ozawa Z, Endo M, Kojima Y, Kozuma K, Suzuki Y, Obayashi K, Takada Y
Department of Radiology, Hyogo Medical Center for Adults.
Nihon Igaku Hoshasen Gakkai Zasshi. 1997 Oct;57(12):801-4.
To evaluate the role of radiation therapy for adrenal metastases.
Fourteen patients, 13 with primary lung carcinoma and one with primary unknown carcinoma, received radiation therapy for adrenal metastases from 1984 to 1995 at the Hyogo Medical Center for Adults. Total dose ranged from 16 Gy to 60 Gy, and fractional dose from 1.6 Gy/ Fr to 3 Gy/Fr.
Partial response of the local tumor was recognized in 2 of 7 patients by CT imaging. Pain relief was obtained in 7 of 8 patients. Median survival was 3 months, and 6-month survival was 28.6% in all patients. Among patients in the symptomatic group, who had complaints of pain due to adrenal mass, survival was even worse (12.5% at 6 months). There were no severe complications, but 4 patients (29%) had gastrointestinal symptoms.
Radiation therapy is useful for the purpose of pain relief in adrenal metastases.
评估放射治疗在肾上腺转移瘤中的作用。
1984年至1995年期间,在兵库成人医疗中心,14例患者接受了肾上腺转移瘤的放射治疗,其中13例原发于肺癌,1例原发癌不明。总剂量为16Gy至60Gy,分次剂量为1.6Gy/分次至3Gy/分次。
通过CT成像,7例患者中有2例局部肿瘤出现部分缓解。8例患者中有7例疼痛得到缓解。所有患者的中位生存期为3个月,6个月生存率为28.6%。在有症状组中,因肾上腺肿块而疼痛的患者,生存情况更差(6个月时为12.5%)。无严重并发症,但4例患者(29%)出现胃肠道症状。
放射治疗有助于缓解肾上腺转移瘤引起的疼痛。